China's drug regulator approved Shanghai Pharmaceuticals' (SHA:601607) vigabatrin oral solution powder, according to a Tuesday filing with the Shanghai bourse.
The drug is indicated for spasms in infants and children ranging from 1 month to 2 years of age.